$PTHS 4 SEC Filings

Filed On	Filing
06 Oct 2026	Form 4: Greenleaf Peter, Director Sold 797 shares ($16.9K)
06 Oct 2026	Form 4: Friedberg Ezra M, Director Sold 558 shares ($11.6K)
06 Oct 2026	Form 4: Pauls Matthew, Director Sold 786 shares ($16.5K)
07 Jul 2026	Form 4: Friedberg Ezra M, Director Sold 558 shares ($14.6K)
07 Jul 2026	Form 4: Pauls Matthew, Director Sold 786 shares ($20.6K)
07 Jul 2026	Form 4: Greenleaf Peter, Director Sold 797 shares ($20.8K)
17 Jun 2026	Form 4: Friedberg Ezra M, Director Sold 283 shares ($7.72K)
15 Jun 2026	Form 4: Davis Todd C, Director Bought 35,948 shares ($1M)
26 May 2026	Form 4: Francis Knuettel Ii, CFO, Treas & Secty Returned 13,947 shares to the issuer · Sold 1,500 shares ($40.3K) · Granted 59,500 Stock Option · 1 more
18 May 2026	Form 4: Friedberg Ezra M, Director Gave up 144 shares to cover exercise price or tax ($3.89K)
06 Apr 2026	Form 4: Malamut Richard, Director Sold 590 shares ($12.3K)
06 Apr 2026	Form 4: Friedberg Ezra M, Director Sold 558 shares ($11.7K)
06 Apr 2026	Form 4: Pauls Matthew, Director Sold 786 shares ($16.4K)
06 Apr 2026	Form 4: Greenleaf Peter, Director Sold 797 shares ($16.7K)
29 Dec 2025	Form 4: Einhorn Andrew J., Director Received 12,000 shares as a grant or award
19 Dec 2025	Form 4: Ligand Pharmaceuticals Inc, Director Disposed of 0 Senior Secured Convertible Note (Disposition to Issuer) · Granted 0 Senior Secured Convertible Note
12 Dec 2025	Form 4: Pauls Matthew, Director Received 8,493 shares by exercise or conversion · Received 2,123 shares by exercise or conversion · Gave 9,542 shares as a gift
26 Nov 2025	Form 4: Friedberg Ezra M, Director Sold 10,000 shares ($280K)
10 Nov 2025	Form 4: Ligand Pharmaceuticals Inc, Director Granted 0 Senior Secured Convertible Note
23 Jul 2025	Form 4: Plesha Scott M., Director Granted 83,678 Restricted Stock Units · Granted 255,000 Stock Option

Comments